Adrenolipoma pathophysiology: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Adrenolipoma}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{CMG}} ==Overview== ==...") |
No edit summary |
||
| Line 19: | Line 19: | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrine system]] | [[Category:Endocrine system]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Overview complete]] | [[Category:Overview complete]] | ||
Revision as of 12:31, 14 August 2015
|
Adrenolipoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Adrenolipoma pathophysiology On the Web |
|
American Roentgen Ray Society Images of Adrenolipoma pathophysiology |
|
Risk calculators and risk factors for Adrenolipoma pathophysiology |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pathophysiology
A myelolipoma may represent a site of extramedullary hematopoiesis. The most widely accepted theory is the existence of metaplasia of the reticuloendothelial cells of blood capillaries in the adrenal gland in response to stimuli such as necrosis, infection, or stress.